CSMS #62097992

Marking Requirements for Repackaged Prescription Medication Imported into the United States

· View this week in context on the trade timeline

Action requiredPolicy GuidanceMedium urgency
Share this messageLinkedInEmail
CSMS # 62097992 - Marking Requirements for Repackaged Prescription Medication Imported into the United States U.S. Customs and Border Protection sent this bulletin at 09/10/2024 09:00 AM EDT CSMS # 62097992 - Marking Requirements for Repackaged Prescription Medication Imported into the United States On June 14, 2024, Regulations and Rulings issued an internal advice decision, HQ H283420, concerning country of origin marking requirements for repackaged prescription medication Imported into the United States.  This ruling may be accessed on the Customs Rulings Online Search System (CROSS) at the following link: rulings.cbp.gov/home . Pursuant to the decision, all repackaged medications sold to retail customers will be required to be marked with the country of origin. The Fact Sheet referenced and found at the link directly below discusses the country of origin marking requirements applicable to prescription medication imported into the United States: cbp.gov/document/fact-sheets/marking-prescription-drugs-retail-sale-factsheet . If you have any questions, please contact the Pharmaceutical Center at PHCMarking@cbp.dhs.gov .

This week in context

This message came out the week of Sept. 7 to Sept. 13, 2024. See that week against the 90 days before it, with every CSMS message by subject and the trade actions behind them.

Trade timeline preview: the week of Sept. 7 to Sept. 13, 2024 highlighted against the 90 days beforeView this week in context on the trade timeline →